CISD3 | OmnibusX

Name	Number of supported studies	Average coverage
natural killer cell	18 studies	24% ± 9%	Explore
macrophage	12 studies	23% ± 9%	Explore
CD16-positive, CD56-dim natural killer cell, human	10 studies	29% ± 8%	Explore
CD8-positive, alpha-beta T cell	9 studies	28% ± 7%	Explore
CD16-negative, CD56-bright natural killer cell, human	8 studies	20% ± 3%	Explore
classical monocyte	8 studies	21% ± 6%	Explore
gamma-delta T cell	8 studies	21% ± 6%	Explore
non-classical monocyte	7 studies	25% ± 9%	Explore
epithelial cell	7 studies	27% ± 12%	Explore
mature NK T cell	6 studies	24% ± 7%	Explore
enterocyte	6 studies	40% ± 20%	Explore
transit amplifying cell	6 studies	41% ± 23%	Explore
mucosal invariant T cell	6 studies	18% ± 2%	Explore
ciliated cell	5 studies	25% ± 7%	Explore
epithelial cell of proximal tubule	5 studies	32% ± 8%	Explore
CD4-positive, alpha-beta T cell	4 studies	27% ± 8%	Explore
conventional dendritic cell	4 studies	28% ± 8%	Explore
intestinal crypt stem cell	4 studies	29% ± 13%	Explore
myeloid cell	4 studies	23% ± 7%	Explore
CD8-positive, alpha-beta memory T cell	3 studies	24% ± 8%	Explore
effector memory CD8-positive, alpha-beta T cell	3 studies	20% ± 3%	Explore
goblet cell	3 studies	32% ± 8%	Explore
monocyte	3 studies	24% ± 3%	Explore
smooth muscle cell	3 studies	19% ± 2%	Explore
progenitor cell	3 studies	57% ± 19%	Explore
T cell	3 studies	20% ± 4%	Explore
endothelial cell	3 studies	23% ± 3%	Explore
alveolar macrophage	3 studies	20% ± 2%	Explore
dendritic cell	3 studies	28% ± 4%	Explore
regulatory T cell	3 studies	28% ± 6%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
liver	100%	3882.54	226 / 226	100%	81.13	406 / 406
thymus	100%	1567.80	653 / 653	100%	36.13	603 / 605
pancreas	100%	1866.06	328 / 328	99%	41.91	177 / 178
intestine	100%	2335.12	966 / 966	99%	66.73	524 / 527
stomach	100%	1768.92	359 / 359	99%	56.62	284 / 286
prostate	100%	1505.46	245 / 245	99%	54.53	498 / 502
skin	100%	1149.05	1805 / 1809	99%	31.94	468 / 472
uterus	100%	1050.45	170 / 170	99%	33.08	454 / 459
brain	100%	1142.37	2631 / 2642	99%	18.58	700 / 705
ovary	100%	776.88	180 / 180	99%	25.04	424 / 430
bladder	100%	1704.76	21 / 21	98%	52.42	496 / 504
kidney	100%	2264.33	89 / 89	98%	35.16	886 / 901
breast	100%	1536.87	459 / 459	98%	48.54	1092 / 1118
lung	99%	1195.71	575 / 578	98%	30.51	1131 / 1155
adrenal gland	100%	2561.41	258 / 258	97%	27.24	223 / 230
esophagus	100%	1387.97	1445 / 1445	96%	24.18	175 / 183
adipose	100%	1561.59	1204 / 1204	0%	0	0 / 0
eye	0%	0	0 / 0	100%	44.52	80 / 80
lymph node	0%	0	0 / 0	100%	31.10	29 / 29
spleen	100%	969.30	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	25.33	45 / 45
ureter	0%	0	0 / 0	100%	74.47	1 / 1
heart	100%	2069.78	860 / 861	0%	0	0 / 0
blood vessel	100%	1334.73	1333 / 1335	0%	0	0 / 0
muscle	100%	1247.37	799 / 803	0%	0	0 / 0
peripheral blood	85%	551.19	786 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

GO_0106034	Biological process	protein maturation by [2Fe-2S] cluster transfer
GO_0005739	Cellular component	mitochondrion
GO_0051537	Molecular function	2 iron, 2 sulfur cluster binding
GO_0046872	Molecular function	metal ion binding

Gene name	CISD3
Protein name	CDGSH iron-sulfur domain-containing protein 3, mitochondrial (MitoNEET-related protein 2) (Miner2) (Mitochondrial inner NEET protein) (MiNT)
Synonyms
Description	FUNCTION: Can transfer its iron-sulfur clusters to the apoferrodoxins FDX1 and FDX2. Contributes to mitochondrial iron homeostasis and in maintaining normal levels of free iron and reactive oxygen species, and thereby contributes to normal mitochondrial function. .
Accessions	ENST00000613478.2 P0C7P0 ENST00000620783.2

CISD3 report